Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis

Journal of Neuroimmunology

Volumn 122, Issue 1-2, 2002, Pages 125-131

  Sorensen, Torben L ^a   Roed, Hanne ^a   Sellebjerg, Finn ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

B cells; Chemokine receptors; Demyelinating disease; Multiple sclerosis

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; INTERFERON BETA SERINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RELAPSE;

ADJUVANTS, IMMUNOLOGIC; ADULT; B-LYMPHOCYTES; CEREBROSPINAL FLUID; DEMYELINATING DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE;

EID: 0036147311     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00453-2     Document Type: Article

References (38)

1. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report
2. In vivo-activated CD4 T-cells upregulate CXC chemokine receptor 5 and reprogram their responses to lymphoid chemokines
3. A chemokine-drive positive feedback loop organizes lymphoid follicles
4. The role of B cells and autoantibodies in multiple sclerosis
5. Chemokines and leukocyte traffic
6. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1alfa and IP-10 are expressed in demyelinating brain lesions
7. Immunoglobulin-containing cells in multiple sclerosis plaques
8. A putative chemokine receptor, BLR1, directs B-cell migration to defined lymphoid organs and specific anatomical compartments of the spleen
9. Blood-brain barrier damage in acute multiple sclerosis plaques: An immunocytochemical study
10. Identification of autoantibodies associated with myelin damage in multiple sclerosis
11. Interferon β-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
12. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS)
13. B cell attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
14. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization
15. Chemokines-chemotactic cytokines that mediate inflammation
16. Progress in determining the causes and treatment of multiple sclerosis
17. Multiple sclerosis
18. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
19. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
20. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
21. Randomized double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
22. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
23. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
24. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines
25. Chemokines
26. Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis
27. CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
28. Magnetic resonance studies of intramuscular interferon-β-1a for relapsing-remitting multiple sclerosis
29. Increased number of CCR5+ interferon-gamma- and tumour necrosis factor-alpha secreting T lymphocytes in multiple sclerosis patients
30. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9
31. Etiology and pathogenesis of multiple sclerosis
32. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
33. Optic neuritis as onset manifestation of multiple sclerosis: A nation-wide long-term survey
34. Chemokines CXCL10 and CCL2: Differential involvement in intrathecal inflammation in multiple sclerosis
35. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis
36. The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes
37. Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
38. Aberrant T cell migration towards RANTES and MIP-1α in patients with multiple sclerosis